Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology company Ceapro has signed a licensing agreement with the University of Guelph for the use of a spearmint variety containing very high levels of rosmarinic acid, a powerful antioxidant and anti-inflammatory.
Subscribe to our email newsletter
Ceapro will apply its patented extraction and processing technologies to create products with cosmeceutical, nutraceutical and pharmaceutical applications.
Mark Redmond, Ceapro’s CEO, said: “We expect our growing distributor network will find broad market appeal and acceptance for a rosmarinic acid that is odourless, tasteless and ingestible. This moves Ceapro’s natural product offerings beyond organics and into nutraceuticals.”